ABL1 Antikörper (N-Term)
Kurzübersicht für ABL1 Antikörper (N-Term) (ABIN219120)
Target
Alle ABL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Detects endogenous levels of total Bcr and the 210kD Bcr-Abl fusion protein. Species cross-reactivity: Human, mouse and rat.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide (KLH coupled) corresponding to the N-terminal sequence of human Bcr. MW of Antigen: 130, 160kD.
Type of Immunogen: Synthetic peptide - KLH conjugated -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, Flo (1:25), ICC (1:100), WB (1:1000)
Usage: Suitable for use in ELISA, Flow Cytometry, Western Blot and Immunocytochemistry. Western Blot: 1:1000. Immunocytochemistry: 1:100. Flow Cytometry: 1:25. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM sodium HEPES, pH 7.5, 150 mM sodium chloride, BSA, 50 % glycerol.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- ABL1 (C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))
-
Andere Bezeichnung
- ABL1 / C-ABL
-
Hintergrund
-
Name/Gene ID: ABL1
Subfamily: Abl
Family: Protein Kinase
Synonyms: ABL1, Bcr/c-abl oncogene protein, Bcr-Abl, Bcr/abl, C-ABL, ABL, JTK7, p150, Tyrosine-protein kinase ABL1, Proto-oncogene c-Abl, V-abl -
Gen-ID
- 25
-
UniProt
- P00519
-
Pathways
- Apoptose, Regulation of Muscle Cell Differentiation, Platelet-derived growth Factor Receptor Signaling, Lipid Metabolism
Target
-